NL-OMON22989
Not yet recruiting
Not Applicable
Detection of Breast Carcinoma with an ICG Enhanced Optical Imaging Device in Breast Cancer Patients.
niversity Medical Center Groningen (UMCG), Department of Surgery.0 sites10 target enrollmentTBD
ConditionsBreast cancer.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast cancer.
- Sponsor
- niversity Medical Center Groningen (UMCG), Department of Surgery.
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blachard DK, Fischer RE, Chiang SB, Elledge R, Mawad ME. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluophore: Feasibility study. Radiology 2008; 246: 734-741.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women above the age of 18 who have biopsy\-proven stage I\-II breast cancer and who are planning to undergo lumpectomy as a treatment for their disease.
Exclusion Criteria
- •1\. Refusal of the patient to be included in the study;
- •2\. Pregnant or breast\-feeding;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Detection of breast carcinoma with an ICG enhanced optical imaging device in breast cancer patients.breast cancerlumpectomy1000629110006295NL-OMON33137niversitair Medisch Centrum Groningen10
Recruiting
Not Applicable
Borstkanker vaststellen met een ademtest met een electronische neusNL-OMON28999Alexander Monro Hospital, BilthovenMedisch Spectrum Twente, EnschedeZiekenhuis Bernhoven, Uden800
Completed
Not Applicable
VEGF imaging for early breast cancer detection.breast cancercancer of the breast10006291NL-OMON35509niversitair Medisch Centrum Groningen47
Unknown
Phase 2
A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast CancerBreast CancerNCT02817334National Cancer Center, Korea149
Not yet recruiting
Not Applicable
Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant ChemotherapyBreast CancerNCT06299202Hospices Civils de Lyon100